RenovoRx, Inc.RNXTNASDAQ
Loading
| Metric | Dec 20 | Dec 21 | Dec 22 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 |
| Operating Income | -3 | -6 | -10 |
| Net Income | -4 | -6 | -10 |
| EBITDA | 0 | -5 | -10 |
| EPS Diluted | -0.25 | -0.40 | -0.54 |
| Metric | Dec 20 | Dec 21 | Dec 22 |
|---|---|---|---|
| Cash & Equivalents | 2 | 15 | 4 |
| Total Current Assets | 2 | 16 | 7 |
| Total Assets | 2 | 16 | 7 |
| Total Current Liabilities | 4 | 1 | 1 |
| Total Liabilities | 17 | 1 | 1 |
| Total Equity | -15 | 15 | 6 |
| Total Debt | 3 | 0 | 0 |
| Net Debt | 1 | -15 | -4 |
| Metric | Dec 20 | Dec 21 | Dec 22 |
|---|---|---|---|
| Operating Cash Flow | -4 | -6 | -9 |
| Capital Expenditure | 0 | -0 | 0 |
| Free Cash Flow | -4 | -6 | -9 |
| Stock-Based Comp | 0 | 0 | 1 |
| Net Change in Cash | -0 | 13 | -11 |